Page last updated: 2024-09-03

vadimezan and Kidney Neoplasms

vadimezan has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azabdaftari, G; Ellis, L; Hammers, H; Lehet, K; Pili, R; Seshadri, M; Shah, P; Sotomayor, P	1

Other Studies

1 other study(ies) available for vadimezan and Kidney Neoplasms

Article	Year
Vascular disruption in combination with mTOR inhibition in renal cell carcinoma. Molecular cancer therapeutics, 2012, Volume: 11, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Antigens; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Everolimus; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Kidney Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Proteoglycans; Sirolimus; Spheroids, Cellular; TOR Serine-Threonine Kinases; Tumor Burden; Xanthones; Xenograft Model Antitumor Assays	2012

Article

Year

Vascular disruption in combination with mTOR inhibition in renal cell carcinoma.

Molecular cancer therapeutics, 2012, Volume: 11, Issue:2

Topics: Angiogenesis Inhibitors; Animals; Antigens; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Everolimus; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Kidney Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Proteoglycans; Sirolimus; Spheroids, Cellular; TOR Serine-Threonine Kinases; Tumor Burden; Xanthones; Xenograft Model Antitumor Assays

2012